Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

534
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
534
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

242
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
242
Emerging Adulthood01:27

Emerging Adulthood

656
Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during...
656
What is Conservation Biology?01:57

What is Conservation Biology?

24.0K
Conservation biology is a scientific field that focuses on the preservation of biodiversity in order to protect ecosystems while meeting the needs of the human population. Humans require properly functioning ecosystems to maintain our supply of natural resources, including food, medicines, and building materials.
24.0K
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

325
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
325
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

524
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
524

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Formulation Engineering of Oral Semaglutide Tablets: Unleashing Gastric Intestinal Permeation with Sodium Caprate.

Pharmaceutics·2026
Same author

Association of Remimazolam-Based Versus Desflurane-Based Maintenance with Early Gastrointestinal Recovery After Laparoscopic Cholecystectomy: A Single-Center Retrospective Cohort Study.

Journal of clinical medicine·2026
Same author

Nursing management competencies among nurses in national specialized hospitals in Korea: a mixed-methods study.

Journal of Korean Academy of Nursing·2026
Same author

Human Turbinate Mesenchymal Stromal Cell-Derived Exosomes Alleviate PM2.5-Induced Pyroptosis via Promoting Mitophagy in Human Vocal Fold Fibroblasts.

Journal of voice : official journal of the Voice Foundation·2026
Same author

Physiological Persistence of Tension Pneumothorax After Minor Diaphragmatic Injury During Laparoscopic Adrenalectomy: A Case Report.

Case reports in anesthesiology·2026
Same author

Process-first relief of emergency department overcrowding: a before-after analysis of time-to-decision and boarding in a regional center.

Clinical and experimental emergency medicine·2026

Related Experiment Video

Updated: Jan 26, 2026

A Precise and Autonomous System for the Detection of Insect Emergence Patterns
06:22

A Precise and Autonomous System for the Detection of Insect Emergence Patterns

Published on: January 9, 2019

6.2K

Emerging PEGylated non-biologic drugs.

Eun Ji Park1,2, Jiyoung Choi1, Kang Choon Lee2,3

  • 1a College of Pharmacy , Chung-Ang University , Seoul , Republic of Korea.

Expert Opinion on Emerging Drugs
|April 9, 2019
PubMed
Summary
This summary is machine-generated.

Polyethylene glycol (PEG)ylation enhances drug value, with over 18 approved products. Recent developments focus on PEGylating non-biologic drugs like small molecules and peptides for extended therapeutic effects.

Keywords:
PEGylationaptamersnon-biologic drugssmall organic moleculessynthetic peptides

More Related Videos

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.2K
Author Spotlight: Exploring Bradysia coprophila's Unique Biology – A Guide to Laboratory Maintenance
04:26

Author Spotlight: Exploring Bradysia coprophila's Unique Biology – A Guide to Laboratory Maintenance

Published on: April 19, 2024

1.7K

Related Experiment Videos

Last Updated: Jan 26, 2026

A Precise and Autonomous System for the Detection of Insect Emergence Patterns
06:22

A Precise and Autonomous System for the Detection of Insect Emergence Patterns

Published on: January 9, 2019

6.2K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.2K
Author Spotlight: Exploring Bradysia coprophila's Unique Biology – A Guide to Laboratory Maintenance
04:26

Author Spotlight: Exploring Bradysia coprophila's Unique Biology – A Guide to Laboratory Maintenance

Published on: April 19, 2024

1.7K

Area of Science:

  • Pharmaceutical Sciences
  • Biotechnology
  • Drug Delivery

Background:

  • PEGylation, attaching polyethylene glycol (PEG), is a key technology for enhancing drug therapeutic value.
  • Over 18 PEGylated products, including enzymes and proteins, are approved by the FDA.
  • While biologics dominate, PEGylation is increasingly applied to non-biologic drugs.

Purpose of the Study:

  • To review recent advancements in PEGylating non-biologic drugs.
  • To highlight the development of PEGylated small organic molecules, synthetic peptides, and aptamers.
  • To discuss the market potential and challenges of PEGylated non-biologic therapeutics.

Main Methods:

  • Literature review of recent developments in PEGylation technology.
  • Analysis of approved PEGylated products and those in clinical development.
  • Examination of therapeutic applications and market trends for PEGylated drugs.

Main Results:

  • PEGylation is expanding beyond biologic drugs to include small molecules, synthetic peptides, and aptamers.
  • Numerous PEGylated non-biologic drugs, including anti-cancer agents and receptor agonists, are in development.
  • PEGylation remains a commercially viable strategy for developing long-acting drug formulations.

Conclusions:

  • PEGylation of non-biologic drugs represents a significant area of pharmaceutical innovation.
  • Emerging PEGylated non-biologic drugs are poised to impact the market significantly.
  • Despite some safety considerations, PEGylation continues to be a valuable approach for drug half-life extension.